About: A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 August 2000

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в серпні 2000 (uk) article scientifique publié en 2000 (fr) im August 2000 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'agostu de 2000 (ast) scientific article published on 01 August 2000 (en)
publication date	wds:Q74216091-2ED9C0B4-5C48-45EA-9B4E-D885E74FCF43
publication date	2000-08-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q74216091-4F560E5E-E5EC-4C61-BE78-E4D420031146
language of work or name	English
author name string	wds:Q74216091-17C56C3E-F2FC-4351-9765-4D382B1316D1 wds:Q74216091-EE1B7B63-94CF-4ABC-ADE5-C8E50B537FDA
author name string	Puhlmann M Bachenheimer LC
rdfs:label	A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver (en) A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver (nl)
skos:prefLabel	A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver (en) A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver (nl)
name	A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver (en) A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver (nl)
author	wds:Q74216091-15AF8F3E-05B7-4E96-896E-F55593F4E4C1 wds:Q74216091-22EB057E-9A0A-41E4-B513-45187C415928 wds:Q74216091-79BD45DB-AAAB-48C6-B843-AB5D49F953D8 wds:Q74216091-F51B9056-CD0B-4A21-8800-798DBAE52F3C
author	Steven Libutti H. Richard Alexander Douglas L. Fraker David L Bartlett
title	wds:Q74216091-11A5E819-A07F-465E-A774-CD102AB61091
title	A phase I-II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver (en)
page(s)	wds:Q74216091-6BA31550-3C9B-45B9-9ED8-4F9A9710C253
page(s)	3062-3070
instance of	wds:Q74216091-6F3CBCB9-2D65-41BD-B766-7173A21D04F7
instance of	scholarly article
main subject	wds:Q74216091-EF7DCB89-E846-41CA-8FB2-7239A637F07F
main subject	ocular melanoma
PubMed ID	wds:Q74216091-E36FD4DB-EF02-4B4A-A7FF-D9F74FD0CBB0
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/10955785
PubMed ID	10955785
published in	wds:Q74216091-E0EC8D8F-53B0-44E1-B437-44BB9666E616
published in	Clinical Cancer Research
issue	wds:Q74216091-E4E63093-0F5A-42C4-8CEA-FF22F1FD974D
volume	wds:Q74216091-180E52F3-E3AF-45EF-8BDC-39CBB0596B61
issue	8
volume	6
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q74216091
is cites work of	Immunoembolization of malignant liver tumors, including uveal melanoma, using granulocyte-macrophage colony-stimulating factor. Insulinoma Treatment of patients with unresectable primary hepatic malignancies using hyperthermic isolated hepatic perfusion. Management of uveal melanoma: a consensus-based provincial clinical practice guideline Phase I study of hepatic arterial melphalan infusion and hepatic venous hemofiltration using percutaneously placed catheters in patients with unresectable hepatic malignancies Isolated hepatic perfusion for patients with liver metastases Isolated hepatic perfusion with 200 mg melphalan for advanced noncolorectal liver metastases Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final results Chemosaturation with percutaneous hepatic perfusion for unresectable metastatic melanoma or sarcoma to the liver: a single institution experience. Cratoxylum formosum (Jack) Dyer ssp. pruniflorum (Kurz) Gogel. (Hóng yá mù) extract induces apoptosis in human hepatocellular carcinoma HepG2 cells through caspase-dependent pathways The biology and management of uveal melanoma Blockade of inhibitors of apoptosis (IAPs) in combination with tumor-targeted delivery of tumor necrosis factor-α leads to synergistic antitumor activity Unleashing endogenous TNF-alpha as a cancer immunotherapeutic Intra-arterial perfusion-based therapies for regionally metastatic cutaneous and uveal melanoma Chemoreduction of Orbital Recurrence of Uveal Melanoma by Intra-Arterial Melphalan Degree of tumour vascularity correlates with drug accumulation and tumour response upon TNF-alpha-based isolated hepatic perfusion A phase I trial of isolated hepatic perfusion (IHP) using 5-FU and oxaliplatin in patients with unresectable isolated liver metastases from colorectal cancer Percutaneous Hepatic Perfusion (PHP) with Melphalan as a Treatment for Unresectable Metastases Confined to the Liver. Hepatic artery infusion of melphalan in patients with liver metastases from ocular melanoma. Chemosaturation Percutaneous Hepatic Perfusion: A Systematic Review Percutaneous Isolated Hepatic Perfusion for the Treatment of Unresectable Liver Malignancies True versus mild hyperthermia during isolated hepatic perfusion: effects on melphalan pharmacokinetics and liver function. Quality of evidence about effectiveness of treatments for metastatic uveal melanoma. Isolated hepatic perfusion as a treatment for liver metastases of uveal melanoma. Doxorubicin Activity Is Enhanced by Hyperthermia in a Model of Ex Vivo Vascular Perfusion of Human Colon Carcinoma
is cites work of	wds:Q30388575-68F8AAD9-B380-43FF-8334-54B0859BB735 wds:Q33937362-68B0EC38-D356-48B7-965F-B09EF42ABFCC wds:Q91739905-3058180C-3A8A-44BA-94CB-3AA0871996B1 wds:Q91717538-A0F8BC1A-F377-4806-8A2A-69FF13603C71 wds:Q64971763-7D943B61-32AD-4A61-B27F-D584AB542DDB wds:Q84739098-D6947783-CF97-4522-90C1-9FEBA6A1EC89 wds:Q28069495-29085713-A651-4CF7-AF55-40699D017AF1 wds:Q37254998-EEE6828E-97BF-403C-8690-09FBF648DC22 wds:Q51679940-3B6C03C3-691F-458C-B818-9CA00E838173 wds:Q50790977-C481A4C0-CE50-4F87-85AC-0F065C04D4DC wds:Q37244719-6F6EC992-EF11-4294-B952-2EC51E3D608E wds:Q36764997-7577D062-96FC-4E13-975D-6DC22709AD12 wds:Q52982266-3DBDB32C-79C4-4422-9836-512B4637D538 wds:Q33186209-581D77BC-1D82-458E-A4A1-3F6A89488CC1 wds:Q36772465-CDC6DFD7-F2FC-4816-99D1-F0D70CF0AC96 wds:Q47909976-1B8EE09C-B487-4B45-812B-1E1FD7BE2C98 wds:Q62711418-3AFCDC59-B34F-42DE-BA4C-9ECF3F2A7446 wds:Q35854809-FCE238D2-2058-4521-A708-BC7EA925A95B wds:Q38734732-D859C4C8-4B6F-4C7A-8D81-2091D84881D5 wds:Q24644011-6173944A-03F2-45E5-B9E6-CC8A615DB4C5 wds:Q36874742-C1D9CD49-1769-4479-8930-747437F157A2 wds:Q58781970-34347212-EFED-46AC-84C6-F4356CE328D2 wds:Q36499644-9D98CAFF-F103-431E-9F85-B46828E8675E wds:Q37412316-3C35B620-A3D5-4DAE-9FEA-0F3E7B9A8A06 wds:Q43181572-C88EFF7F-166C-4575-BCC9-6A3CD83A3240

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 188 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software